CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus

Clinical Cancer Research

Volumn 12, Issue 10, 2006, Pages 2995-3002

  Chang, Moon Sung ^a,c   Uozaki, Hiroshi ^a   Chong, Ja Mun ^a   Ushiku, Tetsuo ^a   Sakuma, Kazuya ^d   Ishikawa, Shunpei ^b   Hino, Rumi ^a   Barua, Rita Rani ^a   Iwasaki, Yoshiaki ^e   Arai, Kuniyoshi ^e   Fujii, Hideki ^c   Nagai, Hideo ^d   Fukayama, Masashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; GLUTATHIONE TRANSFERASE P1; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PROTEIN MLH1; PROTEIN P14; PROTEIN P15; PROTEIN P16; PROTEIN P73; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UVOMORULIN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; FLNC GENE; HAND1 GENE; HRASLS GENE; HUMAN; HUMAN TISSUE; LOX GENE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; METHYLATION; MGMT GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CARCINOMA; TM GENE; VIRUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENES, NEOPLASM; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS (GENETICS); STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 33744789155     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-1601     Document Type: Article

References (26)

1. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004;4:143-53.
2. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004;4:988-93.
3. Osawa T, Chong JM, Sudo M, et al. Reduced expression and promoter methylation of p16 gene in Epstein-Barr virus-associated gastric carcinoma. Jpn J Cancer Res 2002;93:1195-200.
4. Chong JM, Sakuma K, Sudo M, et al. Global and non-random CpG-island methylation in gastric carcinoma associated with Epstein-Barr virus. Cancer Sci 2003; 94:76-80.
5. Sudo M, Chong JM, Sakuma K, et al. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer 2004;109:194-9.
6. INK4A in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer 2004;112:273-8.
7. Kang GH, Lee S, Kim WH, et al. Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 2002;160:784-94.
8. Fukayama M, Chong JM, Uozaki H. Pathology and molecular pathology of Epstein-Barr virus-associated gastric carcinoma. Curr Top Microbiol Immunol 2001; 258:91-102.
9. Toyota M, Afuja N, Suzuki H, et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 1999;59: 5438-42.
10. Kanai Y, Ushijima S, Kondo Y, Nakanishi Y, Hirohashi S. DNA methyltransferase expression and DNA methylation of CpG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int J Cancer 2001;91:205-12.
11. Oue N, Oshimo Y, Nakayama H, et al. DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype. Cancer Sci 2003;94:901-5.
12. Etoh T, Kanai Y, Ushijima S, et al. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol 2004;164: 689-99.
13. An C, Choi IS, Yao JC, et al. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. Clin Cancer Res 2005;11:656-63.
14. INK4A, and E-cadherin in gastric carcinomas with microsatellite instability. J Pathol 2003;200:23-31.
15. Kaneda A, Kaminishi M, Yanagihara K, Sugimura T, Ushijima T. Identification of silencing of nine genes in human gastric cancers. Cancer Res 2002;62: 6645-50.
16. Toyota M, Afuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999; 96:8681-6.
17. Abe M, Ohira M, Kaneda A, et al. CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas. Cancer Res 2005;65: 828-34.
18. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 2nd English edition. Gastric Cancer 1998;1:10-24.
19. Lauren P. The two histological main types of gastric carcinoma, diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965;64:31-49.
20. Fukayama M, Hayashi Y, Iwasaki Y, et al. Epstein-Barr virus infection of the stomach. Lab Invest 1994; 71:73-81.
21. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-6.
22. Kaneda A, Tsukamoto T, Takamura-Enya T, et al. Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation. Cancer Sci 2004;95:58-64.
23. Mikovits JA, Young HA, Vertino P, et al. Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-γ) promoter and subsequent downregulation of IFN-γ production. Mol Cell Biol 1998;18:5166-77.
24. Kaneda A, Wakazono K, Tsukamoto X et al. Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer Res 2004;64:6410-4.
25. Ehrlich M, Jiang G, Fiala E, et al. Hypomethylation and hypermethylation of DNA in Wilms tumors. Oncogene 2002;21:6694-702.
26. Widschwendter M, Jiang G, Woods C, et al. DNA hypomethylation and ovarian cancer biology. Cancer Res 2004;64:4472-80.